Format

Send to

Choose Destination
Clin Infect Dis. 2002 Sep 15;35(6):769-72. Epub 2002 Aug 26.

A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis.

Author information

1
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Abstract

We conducted a trial of oral acetazolamide for the treatment of cryptococcal meningitis in 22 Thai adults with headache and an opening cerebrospinal fluid pressure of >/=200 mm H(2)0. The trial was terminated prematurely because patients who received acetazolamide developed significantly lower venous bicarbonate levels and higher chloride levels and had more-frequent serious adverse events than did subjects who received placebo.

Comment in

PMID:
12203177
DOI:
10.1086/342299
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center